Advisors Preferred’s VanEck Biotech ETF BBH Stock Holding History

Advisors Preferred’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-531	Closed	-$86K	–	168
2020 Q3	$86K	Sell	531 -65	-11%	-$10.6K	0.02%	117
2020 Q2	$98K	Buy	596 +339	+132%	+$51.5K	0.03%	109
2020 Q1	$33K	Buy	+257	New	+$34.6K	0.02%	91
2019 Q2	–	Sell	-542	Closed	-$70K	–	216
2019 Q1	$70K	Buy	+542	New	+$68.5K	0.02%	143
2018 Q4	–	Sell	-138	Closed	-$18K	–	127
2018 Q3	$18K	Buy	+138	New	+$17.9K	0.01%	178
2017 Q3	–	Sell	-547	Closed	-$69K	–	214
2017 Q2	$69K	Buy	547 +374	+216%	+$45.1K	0.04%	123
2017 Q1	$21	Buy	+173	New	+$20.2K	0.01%	168
2015 Q4	–	Sell	-101	Closed	-$12K	–	196
2015 Q3	$12K	Sell	101 -324	-76%	-$42.9K	0.01%	133
2015 Q2	$57K	Buy	+425	New	+$56.5K	0.03%	114
2015 Q1	–	Sell	-20,682	Closed	-$2.39M	–	256
2014 Q4	$2.39M	Buy	20,682 +20,217	+4,348%	+$2.28M	1.12%	26
2014 Q3	$49.2K	Sell	465 -390	-46%	-$39.5K	0.03%	128
2014 Q2	$81.5K	Sell	855 -1,898	-69%	-$170K	0.04%	127
2014 Q1	$250K	Sell	2,753 -28,200	-91%	-$2.74M	0.11%	131
2013 Q4	$2.74M	Buy	+30,953	New	+$2.59M	1.51%	19

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advisors Preferred's BBH Position: Q4 2020 in Review

Advisors Preferred sold out of VanEck Biotech ETF (BBH) in Q4 2020, closing a stake of 531 shares — an estimated $86K sold.

Advisors Preferred first reported a position in BBH in Q4 2013 and held it in 14 quarters. The position peaked at $2.74M in Q4 2013. 108 funds tracked by Wall St. Rank hold BBH as of Q4 2020.

Advisors Preferred reported no remaining VanEck Biotech ETF position as of Q4 2020 after selling out during the quarter.
Advisors Preferred sold 531 VanEck Biotech ETF shares in Q4 2020, an estimated $86K.
Advisors Preferred first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 14 quarters.
Advisors Preferred's VanEck Biotech ETF position peaked at $2.74M in Q4 2013.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2020.

Based on Advisors Preferred's 13F filing for Q4 2020, filed 3 Feb 2021.